• Goldman Sachs invests in Aragen Life Sciences expresspharma
    May 20, 2021
    Aragen Life Sciences, formerly known as GVK Biosciences announced that Goldman Sachs, an active investor in India, has taken a significant minority stake in the company by acquiring shares previously held by ChrysCapital and other existing shareholders.
PharmaSources Customer Service